Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in Histopathology Retrieve available abstracts of 40 articles: HTML format

Single Articles

October 2025
1. PATIL A, Jiezhen TL, Kosiorek H, Brown IS, et al
   An international inter-rater agreement study in the challenging diagnosis of squamous dysplasia of the oesophagus.
   Histopathology. 2025;87:573-583.
   PubMed     Abstract available
   
   
   September 2025
2. ANGERILLI V, Galuppini F, Brignola S, Businello G, et al
   Predictors of neoplastic progression in gastroesophageal lesions indefinite for dysplasia.
   Histopathology. 2025;87:424-435.
   PubMed     Abstract available
   
   
   August 2025
3. RICCI C, Altavilla MV, de Biase D, Corti B, et al
   Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region.
   Histopathology. 2025;87:270-283.
   PubMed     Abstract available
   
   
   June 2025
4. ROSIC D, Khan ZA, Jackson-Boeters L, Darling MR, et al
   Utility of p53 and p16 immunohistochemistry in the diagnosis of human papillomavirus-associated oral epithelial dysplasia: a retrospective study of 105 patients.
   Histopathology. 2025;86:1082-1090.
   PubMed     Abstract available
   
   
   May 2025
5. MOHAMED S, Callanan D, Sheahan P, Feeley L, et al
   Significance of location and extent of perineural invasion in early-stage oral cavity squamous cell carcinoma.
   Histopathology. 2025;86:993-1000.
   PubMed     Abstract available
   
   
   
6. HANKINSON P, Clark M, Walsh H, Khurram SA, et al
   A head-to-head comparison of four grading systems for oral epithelial dysplasia.
   Histopathology. 2025;86:933-941.
   PubMed     Abstract available
   
   
   
7. CHUANG YC, Kuo YJ, Hang JF
   Intranodal thyroid inclusions revisited: a morphological analysis and application of BRAF VE1 immunohistochemistry.
   Histopathology. 2025;86:878-890.
   PubMed     Abstract available
   
   
   
8. ALSUGAIR Z, Lepine C, Fieux M, Descotes F, et al
   Understanding and overcoming the pitfalls in the diagnosis of pleomorphic and carcinoma ex-pleomorphic adenoma of salivary glands.
   Histopathology. 2025;86:1013-1016.
   PubMed     Abstract available
   
   
   April 2025
9. HUA H, Hu D, Ding Y, Li H, et al
   Esophageal submucosal gland duct adenoma: An unrecognised esophageal counterpart of minor salivary gland tumours with frequent BRAF V600E mutations.
   Histopathology. 2025;86:772-778.
   PubMed     Abstract available
   
   
   March 2025
10. BRADOVA M, Costes-Martineau V, Laco J, Vanecek T, et al
    Sinonasal adenosquamous carcinomas arising in seromucinous hamartoma or respiratory epithelial adenomatoid hamartoma with atypical features: Report of five detailed clinicopathological and molecular characterisation of rare entity.
    Histopathology. 2025;86:585-602.
    PubMed     Abstract available
    
    
    
11. DODINGTON DW, Serra S, Bracey T, Chetty R, et al
    Neuroendocrine differentiation and serotonin expression in oesophageal adenocarcinomas after neoadjuvant therapy: correlation with clinicopathological features and outcome.
    Histopathology. 2025;86:559-570.
    PubMed     Abstract available
    
    
    February 2025
12. DABABNEH MN, Azzato EM, Nakitandwe J, Cracolici V, et al
    HMGA2-positive salivary gland neoplasms with prominent trabecular/canalicular morphology: a focus on carcinomas arising within this phenotype.
    Histopathology. 2025;86:385-396.
    PubMed     Abstract available
    
    
    
13. CORBIN H, Yip L, Carty SE, Reyes-Mugica M, et al
    Characterisation of Kursteiner canals of parathyroid: imparting relevance to a one-and-a-quarter-century-old concept.
    Histopathology. 2025;86:341-351.
    PubMed     Abstract available
    
    
    January 2025
14. WOLK RA, Cipriani NA
    Update of newly-recognized salivary gland neoplasms: molecular and immunohistochemical findings and clinical importance.
    Histopathology. 2025;86:183-198.
    PubMed     Abstract available
    
    
    December 2024
15. CHU YH, Katabi N, Sukhadia P, Mullaney KA, et al
    Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions.
    Histopathology. 2024 Dec 4. doi: 10.1111/his.15380.
    PubMed     Abstract available
    
    
    
16. DABABNEH MN, Rabinowitz L, Plitt G, Eng C, et al
    Can thyroid histomorphology identify patients with PTEN hamartoma tumour syndrome?
    Histopathology. 2024;85:929-938.
    PubMed     Abstract available
    
    
    
17. HADNAGY VS, Korner M, Rossle M, Dubach P, et al
    Expanding the spectrum of low-grade sinonasal adenocarcinoma with biphasic seromucinous differentiation and activating HRAS/AKT1 mutations.
    Histopathology. 2024;85:899-908.
    PubMed     Abstract available
    
    
    October 2024
18. DABABNEH MN, Griffith CC, Magliocca KR, Stojanov IJ, et al
    Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases.
    Histopathology. 2024;85:590-597.
    PubMed     Abstract available
    
    
    August 2024
19. HABENBACHER M, Andrianakis A, Gellner V, Braun H, et al
    Aggressive EWSR1::POU2AF3(COLCA2) spindle/round cell sarcoma of the sinonasal tract.
    Histopathology. 2024;85:365-368.
    PubMed    
    
    
    
20. ISRAEL AK, Griffith CC
    Application of the Milan system for reporting salivary gland cytopathology to core needle biopsies of the parotid gland.
    Histopathology. 2024;85:285-294.
    PubMed     Abstract available
    
    
    
21. ALSUGAIR Z, Fieux M, Descotes F, Lopez J, et al
    Peculiar nuclear atypia associated with MDM2 gene amplification in carcinoma ex-pleomorphic adenoma harbouring an alteration of HMGA2.
    Histopathology. 2024;85:338-346.
    PubMed     Abstract available
    
    
    
22. VISWANATHAN K, Hahn E, Dogan S, Weinreb I, et al
    The histological spectrum and immunoprofile of head and neck NUT carcinoma: A multicentre series of 30 cases.
    Histopathology. 2024;85:317-326.
    PubMed     Abstract available
    
    
    July 2024
23. XU B, Roy D, Serrette R, Ghossein R, et al
    Defining angioinvasion and lymphatic invasion in papillary thyroid carcinoma: morphological criteria, utility of D2-40/CD31/ERG immunohistochemistry and correlation with clinicopathological characteristics.
    Histopathology. 2024 Jul 18. doi: 10.1111/his.15285.
    PubMed     Abstract available
    
    
    June 2024
24. LIANG Z, Tang Y, Li C, Xie G, et al
    Oral and oropharyngeal NUT carcinoma: a multicentre screening study of poorly differentiated oral cancer.
    Histopathology. 2024 Jun 20. doi: 10.1111/his.15245.
    PubMed     Abstract available
    
    
    April 2024
25. HEMPENIUS MA, Koomen BM, Deckers IAG, Oosting SF, et al
    Considerable interlaboratory variation in PD-L1 positivity for head and neck squamous cell carcinoma in the Netherlands- A nationwide evaluation study.
    Histopathology. 2024 Apr 12. doi: 10.1111/his.15184.
    PubMed     Abstract available
    
    
    March 2024
26. GHOSSEIN R, Katabi N, Dogan S, Shaha AR, et al
    Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
    Histopathology. 2024 Mar 25. doi: 10.1111/his.15157.
    PubMed     Abstract available
    
    
    
27. RAGAZZI M, Besutti G, Mancuso P, Rossi PG, et al
    Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study.
    Histopathology. 2024 Mar 13. doi: 10.1111/his.15173.
    PubMed     Abstract available
    
    
    
28. CHU YH, Mullaney K, DiNapoli SE, Cohen MA, et al
    FGFR1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.
    Histopathology. 2024;84:589-600.
    PubMed     Abstract available
    
    
    January 2024
29. AKSOY YA, Xu B, Viswanathan K, Ahadi MS, et al
    Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
    Histopathology. 2024 Jan 22. doi: 10.1111/his.15141.
    PubMed     Abstract available
    
    
    
30. MCCLUGGAGE WG
    Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
    Histopathology. 2024;84:288-290.
    PubMed    
    
    
    
31. KATABI N, Sukhadia P, DiNapoli SE, Weinreb I, et al
    Expanding the histological spectrum of salivary gland neoplasms with HMGA2::WIF1 fusion emphasising their malignant potential: a report of eight cases.
    Histopathology. 2024;84:387-398.
    PubMed     Abstract available
    
    
    
32. NEYRAND S, Trecourt A, Lopez J, Just PA, et al
    Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
    Histopathology. 2024;84:291-300.
    PubMed     Abstract available
    
    
    
33. NASO JR, Roden AC
    Recent developments in the pathology of primary pulmonary salivary gland-type tumours.
    Histopathology. 2024;84:102-123.
    PubMed     Abstract available
    
    
    December 2023
34. LOBO J, Rechsteiner M, Rupp NJ, Ostertag H, et al
    Pleomorphic adenoma with PLAG1 fusion as an isolated kidney mass: lessons learned from a challenging case.
    Histopathology. 2023;83:994-996.
    PubMed    
    
    
    
35. VIBERT R, Cyrta J, Girard E, Vacher S, et al
    Molecular characterisation of tumours of the lacrimal apparatus.
    Histopathology. 2023;83:925-935.
    PubMed     Abstract available
    
    
    
36. SUURMEIJER AJH, Cleven AHG, Antonescu CR, Duckworth LA, et al
    Novel EWSR1::GFI1B gene fusion in angiofibroma of soft tissue.
    Histopathology. 2023;83:959-966.
    PubMed     Abstract available
    
    
    November 2023
37. BELLAN E, Patriarca C, Dei Tos AP, Sbaraglia M, et al
    Morphological progression of biphenotypic sinonasal sarcoma to high-grade sarcoma at 7 years from onset.
    Histopathology. 2023;83:825-826.
    PubMed    
    
    
    
38. LANIC MD, Guerin R, Wassef M, Durdilly P, et al
    Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay.
    Histopathology. 2023;83:685-699.
    PubMed     Abstract available
    
    
    October 2023
39. OKUBO Y, Toda S, Sato S, Yoshioka E, et al
    Histological findings of thyroid cancer after lenvatinib therapy.
    Histopathology. 2023;83:657-663.
    PubMed     Abstract available
    
    
    September 2023
40. NADEEM S, Hanna MG, Viswanathan K, Marino J, et al
    Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms.
    Histopathology. 2023 Sep 14. doi: 10.1111/his.15048.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.